BMC Gastroenterology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Feb. 21, 2024
A
number
of
observational
studies
indicate
that
insomnia
is
linked
to
inflammatory
digestive
diseases
(IDDs).
However,
the
definite
relationship
between
and
IDDs
remains
unclear.
Skin Research and Technology,
Journal Year:
2024,
Volume and Issue:
30(2)
Published: Feb. 1, 2024
Abstract
Background
Mounting
evidence
suggest
that
there
are
an
association
between
psoriasis
and
ulcerative
colitis
(UC),
although
the
common
pathogeneses
not
fully
understood.
Our
study
aimed
to
find
potential
crucial
genes
in
UC
through
machine
learning
integrated
bioinformatics.
Methods
The
overlapping
differentially
expressed
(DEGs)
of
datasets
GSE13355
GSE87466
were
identified.
Then
functional
enrichment
analysis
was
performed.
LASSO,
SVM‐RFE
key
module
WGCNA
considered
as
genes.
receiver
operator
characteristic
(ROC)
curve
used
estimate
their
diagnostic
confidence.
CIBERSORT
conducted
evaluate
immune
cell
infiltration.
Finally,
GSE30999
GSE107499
retrieved
validate.
Results
112
DEGs
identified
revealed
they
closely
related
inflammatory
response.
Eight
genes,
including
S100A9,
PI3,
KYNU,
WNT5A,
SERPINB3,
CHI3L2,
ARNTL2,
SLAMF7,
ultimately
ROC
curves
showed
all
had
high
confidence
test
validation
datasets.
indicated
a
correlation
infiltrating
cells
Conclusion
In
our
study,
we
focused
on
comprehensive
understanding
UC.
identification
eight
may
contribute
only
mechanism,
but
also
identifying
occult
patients,
even
serving
therapeutic
targets
future.
Precision Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
6(4)
Published: Oct. 25, 2023
Abstract
Inflammatory
bowel
disease
(IBD)
is
an
incurable
characterized
by
remission-relapse
cycles
throughout
its
course.
Both
Crohn's
(CD)
and
ulcerative
colitis
(UC),
the
two
main
forms
of
IBD,
exhibit
tendency
to
develop
complications
substantial
heterogeneity
in
terms
frequency
severity
relapse,
thus
posing
great
challenges
clinical
management
for
IBD.
Current
treatment
strategies
are
effective
different
ways
induction
maintenance
therapies
Recent
advances
studies
genetics,
pharmacogenetics,
proteomics
microbiome
provide
a
strong
driving
force
identifying
molecular
markers
prognosis
response,
which
should
help
clinicians
manage
IBD
patients
more
effectively,
then,
improve
outcomes
reduce
costs
patients.
In
this
review,
we
summarize
discuss
precision
medicine
focusing
on
predictive
course
monitoring
indices
during
therapeutic
drug
monitoring.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 4, 2025
Inflammatory
bowel
diseases
(IBD)
represent
chronic
inflammatory
multisystemic
disorders
that
primarily
involve
the
gastrointestinal
tract.
Patients
with
ulcerative
colitis
(UC)
and
Crohn’s
disease
(CD)
exhibit
a
higher
prevalence
of
thyroid
compared
to
general
population.
The
aim
this
review
is
summarize
literature
on
concomitant
IBD
disorders,
specifically
autoimmune
such
as
Graves’
(GD)
Hashimoto’s
thyroiditis
(HT),
well
cancer,
focus
children
adolescents.
We
provide
an
overview
age-related
differences
between
adults
in
association.
Literature
shows
relatively
few
studies
have
been
conducted
subject
pediatric
populations.
etiopathogenetic
similarities
are
undeniable.
Nevertheless,
current
data
does
not
indicate
unanimous
association
GD
HT
(both
CD
UC).
Although
evidence
suggests
potential
particularly
papillary
precise
nature
relationship
varies
across
influenced
by
multiple
factors.
limited
information
regarding
highlights
significant
knowledge
gap.
Since
plays
critical
role
population’s
development,
it
essential
promptly
recognize
treat
diseases.
A
function
monitoring
future
research
exploring
genetic
immunologic
connections
enhance
our
understanding
interrelation
disorders.
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 5, 2025
Background
Widespread
use
of
ocrelizumab,
an
anti-CD20
monoclonal
antibody,
for
treating
patients
with
multiple
sclerosis
(MS),
has
led
to
increase
in
reported
adverse
events
following
real-world
observation.
Among
these,
drug-induced
colitis
is
a
rare,
but
severe
side
effect,
prompting
recent
FDA
statement
regarding
this
safety
concern.
Objectives:
We
analyzed
cohort
ocrelizumab
treated
our
MS
center
evaluate
the
incidence
colitis.
Methods
present
critical
review
available
literature
on
diagnosis
and
management
induced
display
case
series
3
suspected
cohort.
Results
Two
met
full
criteria
ocrelizumab-induced
colitis,
while
third
partially
criteria.
Following
symptomatic
treatment
discontinuation
showed
favorable
outcomes.
Conclusion
Ocrelizumab-induced
event.
Its
may
be
higher
than
expected,
reaching
1,95%
patients.
Further
reporting
such
cases
essential
broaden
understanding
effect.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 8, 2024
Introduction
Psoriasis
is
a
T-cell
mediated
autoimmune
skin
disease.
HLA-C*06:02
the
main
psoriasis-specific
risk
gene.
Using
Vα3S1/Vβ13S1
receptor
(TCR)
from
lesional
psoriatic
CD8
+
clone
we
had
discovered
that,
as
an
underlying
pathomechanism,
mediates
response
against
melanocytes
in
psoriasis,
and
identified
epitope
ADAMTS-like
protein
5
(ADAMTSL5)
melanocyte
autoantigen.
The
conditions
activating
genetically
predisposed
individuals
throughout
life
remain
incompletely
understood.
Here,
aimed
to
identify
environmental
antigens
that
might
trigger
autoimmunity
psoriasis
because
of
TCR
polyspecificity.
Methods
We
screened
databases
with
peptide
recognition
motif
for
proteins
containing
peptides
this
TCR.
investigated
immunogenicity
these
patients
healthy
controls
by
lymphocyte
stimulation
experiments
peptide-loaded
tetramers.
Results
wheat,
Saccharomyces
cerevisiae
,
microbiota,
tobacco,
pathogens
activated
both
T
cells
patients.
fluorescent
tetramers
loaded
ADAMTSL5
or
wheat
peptides,
find
same
may
recognize
autoantigen
antigens.
A
wheat-free
diet
could
alleviate
several
Discussion
Our
results
show
due
polyspecificity,
corresponding
previously
suspected
converge
reactivity
pathogenic
thus
be
able
stimulate
melanocytes.
Avoiding
factors
contribute
management
psoriasis.
Therapeutic Advances in Gastroenterology,
Journal Year:
2025,
Volume and Issue:
18
Published: Jan. 1, 2025
Background:
Inflammatory
bowel
disease
(IBD),
including
ulcerative
colitis
(UC)
and
Crohn’s
(CD),
can
affect
the
hepatobiliary
system
pancreas,
substantially
impacting
life
quality
of
patients.
Objectives:
To
evaluate
evidence
comprehensively
assess
validity
associations
IBD
with
pancreatic
diseases.
Design:
We
performed
an
umbrella
review
existing
meta-analyses
in
accordance
Preferred
Reporting
Items
for
Systematic
Review
Meta-Analyses
(PRISMA)
recommendations.
Data
sources
methods:
systematically
searched
PubMed,
Embase,
Web
Science
from
inception
to
April
2024,
identify
appraise
examining
risk
manifestations.
Methodologic
was
assessed
A
Measurement
Tool
Assess
Reviews
(AMSTAR
2)
strength
graded
according
prespecified
criteria.
Results:
total
14
observational
studies
were
included.
The
strongest-validity
suggested
significant
between
gallstones
(odds
ratio
(OR)
=
1.72;
95%
confidence
interval
(CI)
1.40–2.12)
acute
pancreatitis
(OR
3.11;
CI
2.93–3.30).
Highly
suggestive
indicated
a
significantly
increased
cancer
UC
(incidence
rate
(IRR)
2.05;
1.52–2.76)
CD
(IRR
2.31;
1.25–4.28).
In
addition,
highly
that
associated
portal
venous
thrombosis.
Suggestive
showed
higher
prevalence
primary
sclerosing
cholangitis,
non-alcoholic
fatty
liver
disease,
autoimmune
hepatitis,
patients
than
general
population.
Conclusion:
multiple
disorders
varying
levels
magnitude
risk.
Further
high-quality
are
needed
who
more
at
would
benefit
most
screening
prevention
programs.
Trial
registration
(PROSPERO):
CRD42023451461.
Heliyon,
Journal Year:
2025,
Volume and Issue:
11(2), P. e41707 - e41707
Published: Jan. 1, 2025
This
study
aimed
to
explore
the
molecular
mechanisms
of
Lithospermum
erythrorhizon
oil
in
treating
atopic
dermatitis
(AD),
with
a
particular
focus
on
its
regulatory
effect
PI3K-Akt
signaling
pathway.
Utilizing
network
pharmacology
approach
integrated
experimental
validation,
we
identified
active
components
and
potential
targets
via
TCMSP,
ChemSrc,
PubChem,
PharmMapper.
Common
were
selected
by
intersecting
these
AD-related
from
GeneCards.
A
protein-protein
interaction
(PPI)
was
built
using
STRING,
functional
analysis
Gene
Ontology
(GO)
pathway
enrichment
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
performed
Metascape.
Gene-miRNA
constructed
miRTarBase
NetworkAnalyst,
miRNA
functions
annotated
miEAA.
An
AD
mouse
model
induced
DNCB
established
evaluate
oil's
therapeutic
efficacy,
influence
inflammatory
markers,
Fifteen
common
found
be
crucial
pathogenesis.
The
PPI
network,
revealed
interactions
among
13
nodes
42
edges,
Cytoscape
highlighting
10
core
targets.
GO
KEGG
analyses
significant
biological
processes
like
cell
migration
response
regulation,
pathways
such
as
IL-17
signaling.
suggested
may
regulate
miRNAs
hsa-mir-124-3p
hsa-let-7b-5p.
Experimental
results
showed
that
significantly
improved
symptoms
mice,
reduced
IL-4
IL-13
levels,
decreased
p-PI3K,
p-PI3K/PI3K,
p-Akt,
p-Akt/Akt
expression,
inhibiting
activation.
exerts
multi-target,
multi-pathway
effects
AD,
potentially
through
suppressing
Th2-mediated
immune
responses
pathway,
suggesting
novel
avenues
for
treatment
strategies.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 590 - 590
Published: Jan. 17, 2025
Background/Objectives:
Despite
the
increasing
number
of
available
medications,
a
significant
proportion
IBD
patients
fail
to
achieve
current
therapeutic
targets.
Uncontrolled
has
impact
on
patients'
quality
life
and
overall
costs
for
healthcare
system.
Given
complex
pathophysiology
IBD,
Combined
Advanced
Targeted
Therapy
(CATT),
involving
combination
biologics/small
molecules,
appears
have
biological
plausibility
is
gaining
interest.
The
aim
this
narrative
review
provide
evidence
regarding
CATT
in
propose
future
developments
field.
Methods:
Relevant
literature
was
searched
with
pertinent
MeSH
terms
most
important
database.
Results:
Available
provides
encouraging
results
efficacy
effectiveness,
an
acceptable
safety
profile.
may
represent
solution
"difficult-to-treat"
or
concomitant
immune-mediated
inflammatory
diseases.
However,
data
are
restricted
by
low
level
short
follow-up.
Conclusions:
There
no
concluding
superiority
one
therapy
over
another.
Various
schemes
could
be
applied
near
future.
Further
studies
needed
recommendations
integrate
strategy
into
everyday
clinical
practice.